Cite
MLA Citation
M.D. Franken et al.. “Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer.” European journal of cancer, vol. 75, 2017, pp. 204–212. http://access.bl.uk/ark:/81055/vdc_100045081929.0x000001